Meanwhile over at The Diet Doctor site.

The other day I tweeted this "Has The good Diet Doctor been kidnapped and someone spoofing his blog". The reason is because drugs are being praised heavily these days at his site. Now we have Dr.Jason Fung another one of the good guys pushing SGLT2 drugs like an award winning big pharma rep. Check out what the FDA has to say and take it from me, they will pass just about anything these days.

"The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization. We are continuing to investigate this safety issue and will determine whether changes are needed in the prescribing information for this class of drugs, called sodium-glucose cotransporter-2 (SGLT2) inhibitors." http://www.fda.gov/Drugs/DrugSafety/ucm446845.htm

I posted this at this thread at the Doc's earlier, I reckon another banning could be on the horizon. BTW check out the price of the 'wonder drug' http://www.dietdoctor.com/huge-diabetes-news-that-not-many-people-understand-the-significance-of

Best stick with a low carb/keto higher fat diet and regular exercise is my advice to reverse pre/type two diabetes. Fasting very good if you have the self discipline. One thing for sure, no quick fix in a pill and no downside or life threatening side effects in a whole fresh food diet.

Maybe that is why a positive study about how great this type of drugs is. That is typical when a drug has negative effects that may risk the bottom line and these are highly profitable. They try to cover up with a lot of positive spin.

If over the counter drugs that are used by millions and have been around for decades like aspirin and NSAIDS are still discovering new side effects and risks. There is debate on benefit vs risk for is use and new black box warning are been made by the FDA. Why risk your health on a NEW costly drugs that the long term effects aren't well known and does very little to treat the problem diabetics have of high blood glucose.

Time and time again we see next to useless type two drugs being hailed as the way forward, but I never expected to see Dr's  Fung and Eenfeeldt working overtime on there promotion. The $64000 question is why?

yoly wrote:Maybe that is why a positive study about how great this type of drugs is. That is typical when a drug has negative effects that may risk the bottom line and these are highly profitable. They try to cover up with a lot of positive spin.

Yoly nails it yet again.

It reminds me rather horribly what happened when Stephan Guyenet became an official Obesity Researcher and suddenly realised where research grants come from. He actually deleted a bunch of his better blog posts.

A word of caution over Jardiance at Medpage Today

Selected quotes

"It will be 3 to 4 years before the cardiovascular trials of the two other SGLT2 inhibitors -- canagliflozin (Invokana) and dapagliflozin (Farxiga) -- are finished. In the meantime, the suggestion that the lowering of cardiovascular risk is a class effect will remain mostly speculation."

"Long-term studies, as well as studies in older diabetic adults are needed," added Ma. In addition, Lee urged caution. "While SGLT2 inhibitor represents an exciting newest addition to the pharmacotherapy options for individuals with T2DM, its use should be practiced with prudence especially given the recent case reports of euglycemic diabetic ketoacidosis in those with insulin-dependent diabetes and, increased genital infection risk and relatively high cost," she wrote.

http://www.medpagetoday.com/Endocrinology/Diabetes/53698?

So it will be 3 to 4 years before we know of the outcome of the the trials of the other new SGLT2 inhibitors which are already on the market, that makes a mockery of the statements put out that Low Carb can't be recommended due the lack of long term studies 

I left a couple of comments on Diet Doctor, but I expect to be moderated.